Программа на русском языке
5 October, 2009
8.30-9.30
Registration
Venue: Hotel Holiday Inn Sokolniki, Conference Hall "Krimskiy Val"
9.30-11.40
Plenary Session
Chairs: Y. Shevchenko, A. Fassas, А. Kuznetsov
9.30 Y. Shevchenko, MD (Moscow)
Welcome of the President of the Pirogov National Medical Surgical Center
9.40 A. Kuznetsov, MD (Russia)
New Treatment Modalities in Multiple Sclerosis
10.00 A. Marmont, MD (Italy)
Hematopoietic Stem Cell Transplantation for Severe Autoimmune Diseases: History, Progress and Perspectives
10.20 А. Fassas, MD (Greece)
On the Evolution of High Dose Immunosuppressive Therapy with Autologous Stem Cell Transplantation in Multiple Sclerosis
10.40 R. Saccardi, MD (Italy)
Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: An Analysis of the EBMT Database
11.00 А. Gratwohl, MD (Switzerland)
Theoretical and Practical Issues of Autologous vs Allogeneic Stem Cell Transplantation in Multiple Sclerosis
11.20 D.Karussis, MD (Israel)
Bone Marrow Mesenchymal Stem Cells: Immunomodulatory and
Neuroprotective Effects and Their Possible Application in
Neuroinflammatory and Neurodegenerative Diseases
11.40-12.00 Coffee-break
12.00 - 14.30 Oral session 1
International Experience of Autologous Stem Cell Transplantation
in Multiple Sclerosis
Chairs: R. Saccardi, А. Novik, I.Lisukov
12.00 A. Novik, MD, A. Kuznetsov, MD, V. Melnichenko, MD,
D. Fedorenko, MD, T. Ionova, PhD, K. Kurbatova (Russia)
Three Strategies of Autologous Stem Cell Transplantation in Multiple Sclerosis
12.20 T. Kozak, MD, E. Krasulova, MD, E. Havrdova, MD, M. Trneny, MD,
J. Pitha, MD, D. Dolezil, MD, P. Lhotakova, MD, P. Kobylka, MD,
J. Fiedler, MD, V. Koza, MD (Czech Republic)
Immunoablative Therapy with Autologous Stem Cell Support in The Treatment of Patients with Poor Risk Multiple Sclerosis in The Czech Republic
12.40 A. Barreira, MD (Brasil)
A Non-Myeloablative Stem-Cell Transplantation Regimen for the Treatment of Multiple Sclerosis
13.00 L. Su, MD, J. Xu, MD, H. Dong, MD, B. Ji, MD, H. Wuhan, MD, Z. Pu MD (China)
Autologous Peripheral Hematopoietic Stem Cell Transplantation in Secondary Progressive Multiple Sclerosis (China Experience)
13.20 A.Uss, MD, A. Fedulau, MD, N. Milanovich, MD, Y. Motuzova, MD,
V. Zmachinsky MD, A. Baida, MD, P. Mitskevich MD, L. Drazhina, MD (Belarus)
Intermediate-Intensity versus Low-Intensity Conditioning Regimens Followed by Autologous Haematopoietic Stem Cell Transplantation in Patients with Multiple Sclerosis: Results of Belarusian Study
13.40 Dr. K. Langeveld (Germany)
Autologous Stem Cell Transplantation with in-vitro T-Cell Depletion in Refractory Cases of Autoimmune Diseases
13.55 -15.00 Lunch
15.00 - 16.20 Oral Session 2
Treatment Outcomes of Autologous Stem Cell Transplantation
in Multiple Sclerosis
Chairs: A. Marmont, Т. Ionova, A.Uss
15.00 E. Evdoshenko, MD, L. Zubarovskaya, MD, L. Zaslavsky, MD,
A. Skorometz, MD, N. Totolyan, MD, J. Stankevich, MD, S. Alekseev, MD,
E. Morozova, MD, B. Afanasiev, MD (Russia)
Feasibility of High-Dose Сhemotherapy with Autologous Stem Cell Transplantation for Multiple Sclerosis
15.15 R. Ivanov, PhD (Russia)
Immunological Reconstitution after Autologous Stem Cell Transplantation in Multiple Sclerosis
15.30 J. Xu, MD, B. Ji, MD, L. Su, MD, H. Dong, MD, X. Sun, C. Liu (China)
Long Term Outcomes of Autologous Peripheral Blood Stem Cell Transplantation in Progressive Multiple Sclerosis
15.45 M. Odinak, MD, G. Bisaga, MD, V. Chirsky, MD, I. Baldueva, MD, V. Moiseyenko, MD, T. Neckhaeva, MD, N. Kalinina, MD, N. Davidova, MD, M. Paschenkov, MD, C. Ciumas, MD
Autogenic Il-10 Modified Dendritic Cells in Multiple Sclerosis: First Clinical Experience
16.00 A. Uss, MD, A. Fedulau, MD, N. Milanovich, MD, Y. Motuzova, MD, V. Zmachinsky, MD, A. Baida, MD, P. Mitskevich, MD, L. Drazhina, MD
Pregnancy after High-Dose Immunosuppressive Therapy Followed by Autologous Haematopoietic Stem Cell Transplantation in a Patient with Multiple Sclerosis
16.15 D.Fedorenko, MD, Т. Ionova, PhD (Russia)
Symptom Assessment in Early & Late Possttransplant Period after Autologous Stem Cell Transplantation in Multiple Sclerosis
16.30 Т. Ionova, PhD , D. Fedorenko, MD, N. Mochkin, MD, K. Kurbatova,
A. Novik, MD (Russia)
Patient-Reported Outcomes in Multiple Sclerosis Patients Undergoing Autologous Stem Cell Transplantation
16.50 - 17.20 Coffee-break
17.20 - 18.00 Discussion
Panel: R. Saccardi, А. Novik, T.Kozak, А. Kuznetsov, А. Gratwohl,
A. Barreira, B. Afanasiev, A.Fassas, O.Rucavitcin
High Dose Immunosuppressive Therapy with Autologous Stem Cell Transplantation in Multiple Sclerosis: Where are We Now?
What are Further Directions of Research?
18.00-18.25
Patient Advocacy: on Behalf of the Patients' Association
18.25 - 18.30
Concluding Remarks: А. Novik, A.Kuznetsov
Symposium Closing
|
pirogov national medical surgical center
